Home » CellCyte Shares Ride a Wave of Hype
CellCyte Shares Ride a Wave of Hype
For years, the founders of CellCyte Genetics relied on infusions from angel investors to keep their tiny startup afloat. But after Kirkland-based CellCyte combined with a moribund public company, its shares caught fire this fall in the loosely regulated over-the-counter (OTC) market and on Germany’s Frankfurt Stock Exchange.
The Seattle Times
The Seattle Times
Upcoming Events
-
07May
-
14May
-
30May